1. Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma. (September 2019) Authors: Morra, Francesco; Merolla, Francesco; D'Abbiero, Debora; Ilardi, Gennaro; Campione, Severo; Monaco, Roberto; Guggino, Gianluca; Ambrosio, Francesca; Staibano, Stefania; Cerrato, Aniello; Visconti, Roberta; Celetti, Angela Journal: Lung cancer Issue: Volume 135(2019) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CCDC6: the identity of a protein known to be partner in fusion. Issue 7 (26th October 2017) Authors: Cerrato, Aniello; Merolla, Francesco; Morra, Francesco; Celetti, Angela Journal: International journal of cancer Issue: Volume 142:Issue 7(2018) Page Start: 1300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors. (September 2021) Authors: Merolla, Francesco; Ilardi, Gennaro; Di Spigna, Gaetano; Russo, Daniela; Martino, Francesco; Varricchio, Silvia; Dell'Aversana, Giovanni Orabona; Mascolo, Massimo; Covelli, Bianca; Caltabiano, Rosario; Broggi, Giuseppe; Audino, Giovanni; Celetti, Angela; Postiglione, Loredana; Staibano, Stefania Journal: Oral oncology Issue: Volume 120(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. New therapeutic perspectives in CCDC6 deficient lung cancer cells. Issue 9 (24th October 2014) Authors: Morra, Francesco; Luise, Chiara; Visconti, Roberta; Staibano, Stefania; Merolla, Francesco; Ilardi, Gennaro; Guggino, Gianluca; Paladino, Simona; Sarnataro, Daniela; Franco, Renato; Monaco, Roberto; Zitomarino, Federica; Pacelli, Roberto; Monaco, Guglielmo; Rocco, Gaetano; Cerrato, Aniello; Linar... Journal: International journal of cancer Issue: Volume 136:Issue 9(2015:May 01) Page Start: 2146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis. Issue 11 (November 2021) Authors: Morra, Francesco; Merolla, Francesco; Zito Marino, Federica; Catalano, Rosaria; Franco, Renato; Chieffi, Paolo; Celetti, Angela Journal: Heliyon Issue: Volume 7:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis. Issue 11 (November 2021) Authors: Morra, Francesco; Merolla, Francesco; Zito Marino, Federica; Catalano, Rosaria; Franco, Renato; Chieffi, Paolo; Celetti, Angela Journal: Heliyon Issue: Volume 7:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis. Issue 11 (November 2021) Authors: Morra, Francesco; Merolla, Francesco; Zito Marino, Federica; Catalano, Rosaria; Franco, Renato; Chieffi, Paolo; Celetti, Angela Journal: Heliyon Issue: Volume 7:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer. (28th April 2022) Authors: Miro, Caterina; Di Giovanni, Angelo; Murolo, Melania; Cicatiello, Annunziata Gaetana; Nappi, Annarita; Sagliocchi, Serena; Di Cicco, Emery; Morra, Francesco; Celetti, Angela; Pacifico, Francesco; Imbimbo, Ciro; Crocetto, Felice; Dentice, Monica Journal: Cancer letters Issue: Volume 532(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic. Issue 1 (December 2016) Authors: Cerrato, Aniello; Morra, Francesco; Celetti, Angela Journal: Journal of experimental & clinical cancer research Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs. (May 2017) Authors: Malapelle, Umberto; Morra, Francesco; Ilardi, Gennaro; Visconti, Roberta; Merolla, Francesco; Cerrato, Aniello; Napolitano, Virginia; Monaco, Roberto; Guggino, Gianluca; Monaco, Guglielmo; Staibano, Stefania; Troncone, Giancarlo; Celetti, Angela Journal: Lung cancer Issue: Volume 107(2017) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗